Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally.
Media
Zentiva’s latest press releases, media assets, global media contacts and social media links
Press releases and publications
-
July 9, 2025 / 2025
-
June 30, 2025 / 2025
As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels.
-
June 16, 2025 / 2025
Propol2 EMF, Ruscoven, Serenil, Fisiodepur and Finocarbo will become part of Zentiva’s portfolio
-
May 30, 2025 / 2025
At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.
-
May 21, 2025 / 2025
Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”
-
May 15, 2025 / 2025
Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025.
-
July 9, 2025 / 2025
Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally.
-
June 30, 2025 / 2025
As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders, and partners for its annual meeting in Brussels.
-
June 16, 2025 / 2025
Propol2 EMF, Ruscoven, Serenil, Fisiodepur and Finocarbo will become part of Zentiva’s portfolio
-
May 30, 2025 / 2025
At Zentiva, we believe that each of us can contribute to taking care of our planet and doing what we can to protect it so that future generations can enjoy life as much as we do.
-
May 21, 2025 / 2025
Zentiva supported Euractiv’s Health Policy Conference in Brussels, where its CEO, Steffen Saltofte, joined senior EU policymakers in the opening panel titled “The EU Pharmaceutical Legislation – Ensuring Fair Access to Medicines for All.”
-
May 15, 2025 / 2025
Zentiva proudly participated in the 93rd European Atherosclerosis Society (EAS) Congress, held in Glasgow from May 4-7, 2025.
-
December 17, 2024 / 2024
Key takeaways included the emerging risk of medicine shortages. This not only contradicts the solidarity principle of the European Union but also burdens the industry with added costs and administrative demands.
-
December 9, 2024 / 2024
-
November 18, 2024 / 2024
-
November 12, 2024 / 2024
We are proud to announce that Zentiva has successfully achieved the SAP Customer Center of Expertise (CCoE) certification.
-
November 8, 2024 / 2024
In this episode, you will learn about data from beehive colonies turned into smart insights, helping us determine the ecological impact humans have in a certain area. In a nutshell, this AI-driven project uses bees as our smart environmental sensors to achieve sustainability goals.
-
December 18, 2023 / 2023
The General Assembly focused on critical issues such as EU pharmaceutical legislation that delivers on accessibility, affordability and availability of the medicines, removing any barriers and delays, and environmental impact.
-
December 14, 2023 / 2023
As a leader in the pan-European pharmaceutical platform, Zentiva actively shares its experience and explores advancements in energy efficiency management through its participation in dedicated events.
-
November 14, 2023 / 2023
We act today for a sustainable tomorrow continuously reducing our environmental impact and we are on our path to becoming carbon neutral in 2030.
-
October 24, 2023 / 2023
CPHI is one of the largest and most sought-after event in the pharmaceutical industry. We are excited to meet and discuss with our current, as well as future potential partners.
-
December 22, 2021 / 2021
Zentiva opens vaccination site for employees and their families at its Prague plant
-
November 3, 2021 / 2021
-
October 12, 2021 / 2021
-
September 24, 2021 / 2021
-
September 16, 2021 / 2021
-
October 25, 2019 / 2019
Zentiva Acquires Central and Eastern European Business of Alvogen
-
September 11, 2019 / 2019
Zentiva enhances its global manufacturing footprint by signing an agreement to acquire manufacturing site in Ankleshwar, India
-
May 31, 2019 / 2019
Zentiva announces completion of Solacium Pharma acquisition
-
April 1, 2019 / 2019
Zentiva Group a.s. is announcing the acquisition of Creo Pharmaceuticals Ltd. in the UK, a subsidiary of Amneal Pharmaceuticals, Inc. (NYSE: AMRX).
-
March 13, 2019 / 2019
Zentiva Group a.s. and Siyiara Enterprises have signed a Shared Purchase Agreement for the acquisition of Romanian based pharmaceutical company Solacium, together with its subsidiary Be Well Pharma.
-
November 23, 2018 / 2018
Zentiva and PHOENIX joined forces this week for an inaugural Annual Partnership meeting in Prague to kick off a strategic partnership between the two healthcare companies in Europe.
-
October 1, 2018 / 2018
oday marks generics manufacturer Zentiva’s first day as an independent organization, following completion of the company’s previously announced divestment from Sanofi.
-
June 28, 2018 / 2018
Sanofi and Advent International (“Advent”) have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion (enterprise value).
Media library
Browse through our media resources at your disposal.
Logo
 |
|
|
 |
Pantone |
2727 |
 |
Pantone |
339 |
- Photos of Zentiva Headquarter (zip, 64 MB)
- Sustainability at Zentiva (zip, 27 MB)
- Photos of Production sites (zip, 81 MB)
- Photos of R&D (zip, 7 MB)
Social media
We invite you to follow our LinkedIn pages were we share key business updates, awareness campaigns and job opportunities.
Explore our other LinkedIn accounts:
Media contacts
Do you need to get in touch with us? Reach out to our media contact with your enquiries.
Marie-Claire Rees
Head of Communications
Telephone: (+420) 267 241 111
Email: zentiva@zentiva.com